Upper Limb Treatment With "Gloreha Aria" in the Hemiplegic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-01

Study Completion Date

2021-09-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke is one of the leading causes of death and disability and has been described as a worldwide epidemic (1). Stroke survivors are affected by impairments and limitations of cognitive, language, perceptual, sensory, and motor functions. After a stroke, patients can improve spontaneously within the first 3 months (2) and then more slowly in the following year. The first day, decreased oedema and partial reperfusion of the ischemic penumbra may possibly explain these phenomena, but the improvement of neurological deficit in the following weeks suggests plasticity phenomena and brain cortical reorganization (3). While most recovery is thought to be made in the first few weeks after stroke, patients may make improvements on functional tasks many months after having a stroke (4). Restoring arm and hand skill after a stroke remains challenging, even though stroke rehabilitation programs have proven partial efficacy Repetitive task training has been shown to be effective in some aspects of rehabilitation, such as improving walking distance and speed and improving upper limb function (5).

In this project, the investigators will use "Gloreha ARIA" (7) a new sensor-based therapy device designed for motor recovery of impaired upper limb Gloreha Aria offers specific programs that help patients to move arm, wrist and fingers. Therapists can customize therapy by focusing on a specific motor task.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility and Efficacy of a Robotic Device for Hand Rehabilitation

NCT02628418

Stroke Upper Extremity Hemiplegia Disorder of Hand

COMPLETED NA

Efficacy of Robot-Assisted Rehabilitation of Hand Paralysis After Stroke

NCT02711787

Stroke

COMPLETED NA

The Efficacy of Upper Limb Rehabilitation With Exoskeleton in Patients With Subacute Stroke.

NCT04697368

Stroke Upper Extremity Paresis

ACTIVE_NOT_RECRUITING NA

Robotic Rehabilitation of the Upper Limb in Subacute Stroke

NCT06839482

Stroke

RECRUITING NA

Mirror Therapy Efficacy in Upper Limb Rehabilitation Early After Stroke

NCT03418883

Stroke, Acute

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hypothesis was that rehabilitation with this device could be not inferior in comparison with hands-on physiotherapy, in the reeducation of upper arm in the patient affected by stroke from cerebral ischemia or hemorrhage that had occurred ≤ 30 days before.

The principle purpose of this study will be to evaluate:

1. The feasibility of this new device
2. Efficacy in improving arm function abilities in the rehabilitation of patients with stroke in the sub-acute phase.

Post-stroke patients admitted for inpatient rehabilitation to the Neurological Rehabilitation will be screened for enrolment and randomized in a controlled trial.

All the patients will be informed about the aim and experimental procedures before enrolment, thus written informed consent will be obtained from all of them. Patients included in the study will be randomly assigned to intervention or control group according to simple randomization technique (computerized random numbers).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiplegia and/or Hemiparesis Following Stroke Upper Extremity Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group

The specific hand intervention consisted of 30 sessions, lasting 60 min/ day, for 6 days/week. All patients will be educated by physiotherapist to perform the movements for wrist, hand and arm in complete autonomy.

In Treatment Group, the movements will be performed using Gloreha ARIA. Gloreha Aria is a sensor-based therapy device designed for motor recovery of impaired upper limb. Gloreha Aria is equipped with sensors that can detect any movements in space: the software processes and displays them on the screen.

Group Type EXPERIMENTAL

Gloreha Aria

Intervention Type DEVICE

Device offers specific programs that help patients to move arm, wrist and fingers

Participants Usual Care (PUC)

The specific hand intervention consisted of 30 sessions, lasting 60 min/ day, for 6 days/week. All patients will be educated by physiotherapist to perform the movements for wrist, hand and arm in complete autonomy.In Control Group, these activates will be performed without any device.

Group Type ACTIVE_COMPARATOR

Usual care

Intervention Type OTHER

Conventional occupational therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gloreha Aria

Device offers specific programs that help patients to move arm, wrist and fingers

Intervention Type DEVICE

Usual care

Conventional occupational therapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* to exhibit first cerebral vascular disease with unilateral hemispherical lesion confirmed by CT scan or MRI;
* to be sub-acute patients (less than 30 days from the cerebral vascular event);
* being affected by upper limb paresis;

Exclusion Criteria

1. unable to understand verbal instruction or motor commands;
2. unilateral neglect;
3. apraxia;
4. significant visual impairment;
5. unstable medical condition;
6. significant orthopedic limitation to the shoulder, elbow; wrist and hand;
7. upper arm peripherical nerve lesion;
8. neuromuscular or neurodegenerative diseases;
9. spasticity \> 3 in according to the Modifies Ashworth Scale (3);

Eligible Sex

ALL

Accepts Healthy Volunteers

No